Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer

2017 ◽  
Vol 79 (5) ◽  
pp. 873-880 ◽  
Author(s):  
JoungSoon Jang ◽  
Hoon-Kyo Kim ◽  
Byoung Chul Cho ◽  
Kyung Hee Lee ◽  
Hwan-Jung Yun ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii Study ◽  
Performance Status ◽  
Poor Performance ◽  
Small Cell ◽  
Poor Performance Status ◽  
Small Cell Lung ◽  
Weekly Docetaxel ◽  
Randomized Phase Ii

scholarly journals Phase II Study of Docetaxel and Celecoxib, a Cyclooxygenase-2 Inhibitor, in Elderly or Poor Performance Status (PS2) Patients with Advanced Non-small Cell Lung Cancer

2008 ◽  
Vol 3 (11) ◽  
pp. 1293-1300 ◽  
Author(s):  
Shirish M. Gadgeel ◽  
Antoinette Wozniak ◽  
John C. Ruckdeschel ◽  
Lance K. Heilbrun ◽  
Raghu Venkatramanamoorthy ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Performance Status ◽  
Poor Performance ◽  
Small Cell ◽  
Poor Performance Status ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document